ADVERTISEMENT
Illustration of DNA
Can “Gene Writing” Deliver What Gene Editing Can’t?
A biotech startup called Tessera Therapeutics has made a splash with its claims about the trademarked technology. Is the excitement justified?
Can “Gene Writing” Deliver What Gene Editing Can’t?
Can “Gene Writing” Deliver What Gene Editing Can’t?

A biotech startup called Tessera Therapeutics has made a splash with its claims about the trademarked technology. Is the excitement justified?

A biotech startup called Tessera Therapeutics has made a splash with its claims about the trademarked technology. Is the excitement justified?

biotech

2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist Staff | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
the facade of a building. crisscrossed white walls intersect sets of four black windows in a lattice structure, with a cloudless blue sky in the background.
Exosome Scientist Douglas Taylor Stole and Mislabeled Images: Report
Katherine Irving | Nov 23, 2022 | 2 min read
Taylor, formerly of the University of Louisville, is known for his discovery of and research on tumor-secreted exosomes.  
Photograph of scientists working while wearing PPE
Contract Vivarium Facilities for Preclinical Discovery
The Scientist’s Creative Services Team and Mispro | 3 min read
Researchers rent contract vivarium space for greater experimental control, productivity, and reproducibility when developing new therapeutics.
Updated July 27
Magnifying glass in front of a stack of files of papers
PLOS ONE Pulls Five Papers Tied to Alzheimer’s Drug Controversy
Jef Akst | Mar 31, 2022 | 2 min read
The retracted studies were coauthored by a scientist who worked on an Alzheimer’s therapy in development by Cassava Sciences, a company reportedly under investigation for providing falsified data to the FDA.
Photo of lab-grown chicken from Eat Just, Inc.
Cultured Meat Advances Toward the Market
Abby Olena, PhD | Feb 14, 2022 | 8 min read
The biotech industry is chipping away at the obstacles standing between the lab and the dinner plate.
Learn How Multiomics Drives Biotherapeutic Discovery and Development
Advancing Biotherapeutics with Multiomics
The Scientist’s Creative Services Team and Tecan | 1 min read
Explore how biomolecular processes drive health and disease.
New ideas and imagination Creativity and inspiration Technological innovation.
Innovations that Matter
Bob Grant | Dec 1, 2021 | 3 min read
Scientific advances almost always have the potential to benefit human lives. In times like these, they have the power to save them.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist Staff | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Learn How Cutting-Edge Science is Breaking Through Industry Barriers
Focus on Innovation: Scientific Advances Driving Biopharma Market Trends
The Scientist’s Creative Services Team and Tecan | 1 min read
Explore the future of biopharma research and development.
photograph of miSHERLOCk device against a white background
A Self-Contained COVID-19 Test with 3-D Printed Parts
Annie Melchor | Aug 11, 2021 | 7 min read
The makers of the CRISPR-based testing platform, called miSHERLOCK, say it could enable people at home or physicians in resource-limited environments to detect SARS-CoV-2—and eventually, other pathogens.
photograph of a woman wearing a face mask embedded with SARS-CoV-2 sensors
Researchers Create Pathogen-Sensing Face Mask
Annie Melchor | Jul 5, 2021 | 5 min read
The masks contain freeze-dried, cell-free biosensors, enabling them to detect pathogens including SARS-CoV-2.
40422-lt-highqualityscreening-800x560
High-Quality Screening and Target Validation During Drug Development
The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific | 1 min read
Drew Adams will discuss his work developing therapeutics that promote remyelination for neurological diseases.
Women looks at computer screen in a lab coat and mask
Quest for Research Freedom Fuels African Biotech Boom
Linda Nordling | Jul 1, 2021 | 6 min read
Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.
Opinion: Europe Is Sinking Biotech—Again
Robert Paarlberg | Feb 1, 2021 | 3 min read
Scientifically groundless regulations could undercut the potential of gene-edited crops, much as they have with GMOs.
Starting a New Lab
The Scientist’s Creative Services Team | 1 min read
Advice for new principal investigators starting their first research laboratories!
The Rise of BCI Enables Advances in Neuroscience
Jef Akst | Oct 1, 2020 | 10+ min read
A nascent but growing consumer market for brain-computer interface technology is driving the development of sleek new tools for decoding brain activity.
Can Zapping the Brain Boost Memory?
Diana Kwon | May 1, 2020 | 5 min read
The California-based company Humm has developed a “bioelectric memory patch” to improve working memory, but some experts question the efficacy of the device.
It Takes Less Than 30 Days to Compost a Human Body
Jef Akst | Feb 17, 2020 | 2 min read
In a small trial of deceased volunteers, a Seattle-based company called Recompose demonstrates that its method for “natural organic reduction” of a human body completely breaks down soft tissue.
Gene Therapy Finds a Fertile Home in Ohio
Shawna Williams | Jan 13, 2020 | 8 min read
The midwestern state has quietly laid the groundwork for a biotech hub.
ADVERTISEMENT